Covered recipient · General Payments record
MATTHEW D BLAKE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2025
$3,397.88
- Reported across 90 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $916.99 | 48 |
| Education | $915.00 | 1 |
| Travel and Lodging | $892.49 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $1,834.03 | 4 |
| Teva Pharmaceuticals USA, Inc. | $81.22 | 4 |
| ABBVIE INC. | $73.12 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $66.05 | 4 |
| Corcept Therapeutics | $63.76 | 3 |
| GlaxoSmithKline, LLC. | $59.56 | 2 |
| Otsuka America Pharmaceutical, Inc. | $54.72 | 3 |
| Insulet Corporation | $54.25 | 3 |
| Novo Nordisk AS | $49.65 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $45.40 | 3 |
| Exact Sciences Corporation | $33.21 | 2 |
| PFIZER INC. | $27.78 | 2 |
| Tandem Diabetes Care, Inc. | $25.99 | 1 |
| Vanda Pharmaceuticals Inc. | $24.94 | 1 |
| DEXCOM, INC. | $23.89 | 1 |
| Lundbeck LLC | $23.65 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.66 | 1 |
| Alkermes, Inc. | $18.60 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.50 | 1 |
| Amgen Inc. | $18.43 | 1 |
| Xeris Pharmaceuticals, Inc. | $17.32 | 1 |
| Lilly USA, LLC | $15.56 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.55 | 1 |
| Supernus Pharmaceuticals, Inc. | $15.53 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.25 | 1 |
| ITI, Inc. | $14.04 | 1 |
| Acerta Pharma LLC | $13.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (51)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.